The Pharmacotherapy Research Center (PRC) is a collaborative hub for the School of Pharmacy and Pharmaceutical Sciences

Go To:

Main Menu

Research Operations & Training

Training opportunities

IInternational Programs

National Institute of Allergies and Infectious Diseases(NIAID)

National Institute of Mental Health (NIMH)

National Institute on Drug Abuse (NIDA)

Sponsored Programs

Core Analytical Laboratory

You do not have JavaScript enabled. Some portions of this website will not work properly without it. Please click here to find out how to enable JavaScript on your browser.

University at Buffalo, the State University of New York School of Pharmacy and Pharmaceutical Sciences

2004-05
2005-06
2006-07
2008-09

FY 08-09 Tsuji, Brian

2008-2009 Active Projects
Faculty Member	Grant Title	Role	Sponsor
Morse, Gene D.	Disulfiram Interactions with HIV Medications: Clinical Implications	PI	NIH -NIDA - University of California at San Fransico
Morse, Gene D.	Adherence Project	PI	ECMC- NYS
Morse, Gene D.	HIV Treatment Education	PI	ECMC- Ryan White
Morse, Gene D.	International Center for Pharmacotherapy Research and Training	PI	Gilead Foundation
Morse, Gene D.	Opoids and Medications; Interactions in Drug Abusers (Subcontract: McCance)	Co-I	NIH-NIDA UCSF
Morse, Gene D.	Targeted Neuro-Protection of HIV-1 Associated Neurologic Diseases-Subcontract: Schifitto	PI	NIH - NIMH
Morse, Gene D.	ACTG Pharmacology Support Laboratory (Task Order 1 and 3)	PI	Social & Scientific Systems
Morse, Gene D.	Pharmacology Quality Assurance and Quality Control (CPQA)	PI	NIH- NIAD
Morse, Gene D.	Centers for AIDS Reseasrch: D-CFAR	Mentor	University of Rochester
Morse, Gene D.	Pharmacokenetic Interactions between buprenophine and Kaletra	PI	Yale
Morse, Gene D.	TDM& Drug Interactions in HIV Infected Substance Abusers	PI	NIH - NIDA
Morse, Gene D.	TDM-Drug Interactions Studies of Buprenorphine and HAART in HIV-Infected patients	PI	NIH - NIDA
Morse, Gene D.	TDM-Drug Interactions & Antiretrovirals in Resource-Poor Countries	PI	NIH -NIDA
Morse, Gene D.	UB-UZ AIDS International Training and Research Program<(Subcontract: Reingold)	Co-I	NIH-Fogarty International Center- Univ of California at Berkley
Forrest, Alan	Optimizing Dosing of Colistin for Infection Resistant to all other Antibiotics ( Subcontract: Patterson )	PI	NIH - University of Pittsburgh
Tornatore, Kathleen	The Relationship of Drug Exposure and Immunodynamic Responses during Myfortic® therapy in Stable African American and Caucasians Renal Transplant Recipients	PI	Novartis
Tsuji, Brian	Targeting MDR hetero-resistant Gram-negatives: PK/PD for rational combinations (Subcontract: Nation)	PI	NIH - Monash University
Tsuji, Brian	Epidemiology of Vancomycin Suseptible Phenotypes -	PI	UNYCHRQ
Tsuji, Brian	PK/PD/PG Models for the Dynamics of Bacterial Responses to Peptide Antibiotics	Co-I	Center for Protein Theraputics
Profiling the Evlolution of Vancomycin Resistance in Staphyloccus aureus-	PI	Pfizer
Tsuji, Brian	Optimizing Linezolid Dosing to Prevent the Emergence of Reisstance in Staphyloccus aureus	PI	Pfizer
Tsuji, Brian	Activity of Daptomycin against Staphyoccus aureus hemB Mutants expressing small colony variant Phenotype	PI	Cubist

FY 06-07

Faculty Member	Grant Title	Role (PI or CoI)	Sponsor
Bednarczyk, Edward	An open label Phase 1 study to assess central D2/D3 Receptor occupancy using Positron emission Tomography (PET) following multiple oral dose administration of PF-00217830 in the healthy adult	PI	Pfizer

Havard, Patty	PCN Pharmacokinetic Study	PI	Harvard Medical Faculty Physicians

Morse, Gene	Ryan White Title III	PI	Health Resources And Services Administration

Morse, Gene	NYSDOH Adherence	PI	New York State Department of Health

Morse, Gene	Opiods and HIV Medications; Interactions in Drug Abusers	PI	Virginia Commonwealth University- Subcontract From National Institute On Drug Abuse

Morse, Gene	Adult Therapeutic Clinical Trials Program for AIDS	PI	University Of Rochester

Morse, Gene	TDM & Drug Interactions in HIV Infected Substance Abusers	PI	National Institute On Drug Abuse

Morse, Gene	AACTG Pharmacology Support Laboratory	PI	National Institute of Allergy and Infectious Diseases

Morse, Gene	AACTG Pharmacology Support Laboratory QA/QC	PI	National Institute of Allergy and Infectious Diseases

Morse, Gene	ACTG-5146 Laboratory Services	PI	Virco

Tornatore, Kathleen	The Relationship of Drug Exposure Immunodynamic Response During Myfortic Therapy in Stable African American and Caucasian Renal Transplant Recipients	PI	Novartis

FY 05-06

Faculty Member	Grant Title	Role (PI or CoI)	Sponsor

Bednarczyk, Edward	Central D2 Receptor Occupancy in Schizophrenia Patients following Multiple Oral Doses of CP-903,397 Using [11C] Raclopride -Protocol #5401003	PI	Pfizer

Dicenzo, Robert	Optimizing Adjuvant Chemotherapy in Obese and Overweight Women	PI	American College of Clinical Pharmacy

Dicenzo, Robert	Pharmacokinetics of Lopinavir in Plasma and CSF of HIV Infected Adults	PI	University of Rochester

Haas, Curtis	Kinetics and Dynamics of IV Enoxaparin in the Trauma ICU	PI	American College of Clinical Pharmacy

Haas, Curtis	Collaborative program in pharmacotherapy research, practice and clinical education relative to critically ill patients	PI	University of Rochester

Morse, Gene	Ryan White Title III	PI	Health Resources & Services Administration

Morse, Gene	NYSDOH Adherence	PI	New York State Department of Health

Morse, Gene	Opiods and HIV Medications; Interactions in Drug Abusers	PI	Virginia Commonwealth University – Subcontract From National Institute on Drug Abuse

Morse, Gene	Adult Therapeutic Clinical Trials Program for AIDS	PI	University of Rochester

Morse, Gene	TDM & Drug Interactions in HIV Infected Substance Abusers	PI	National Institute on Drug Abuse

Morse, Gene	Drug Interactions and Antiretrovirals in Resource Poor Countries (International Supplement)	PI	National Institute on Drug Abuse

Morse, Gene	Drug Interaction Studies of Buprenorphine (Administrative Supplement)	PI	National Institute on Drug Abuse

Morse, Gene	TDM and Drug Interactions in HIV Infected Substance Abusers	PI	National Institute on Drug Abuse

Morse, Gene	Summer Research with NATIONAL INSTITUTE ON DRUG ABUSE	PI	National Institute on Drug Abuse

Morse, Gene	AACTG Pharmacology Support Laboratory	PI	National Institute of Allergy and Infectious Diseases

Morse, Gene	AACTG Pharmacology Support Laboratory QA/QC	PI	National Institute of Allergy and Infectious Diseases

Morse, Gene	ACTG-5146 Laboratory Services	PI	Virco

Morse, Gene	Evaluation of Patient-Centered Pharmacotherapy Management	PI	Multi-Sources

Morse, Gene	Contemporary Practices of Pharmacists & Pharmacy Technicians	PI	American College of Clinical Pharmacy

Schroeder, Walt	Assessment of Eptifatide Dosing in Patients with Renal Dysfunction	PI	University of Massachusetts

Smith, Patrick	A Phase I, Open-Label, 2-Period, Single Sequence, Drug Interaction Study to Assess Steady-State Plasma Methadone Enantiomer Pharmacokinetics Following Co-Administration of Methadone QD with Fosamprena	PI	GlaxoSmithKline

Smith, Patrick	The Effect of Co-Administration of "Boosted" Saquinavir and Methodone on the PK	PI	Hoffman Laroche

Tsuji, Brian	Optimizing Antibiotic Dosing in Staphyloccus aureus Bloodstream Infection	PI	Interdisciplinary Research Development Fund

FY 04-05

Faculty Member	Grant Title and grant number	Role (PI, co-PI, contractor, consultant, etc.)	Sponsor

Ed Bednarczyk	Coenzyme CoQ10 Bioequivalence Study, 9103-524835,	PI	Pfizer

Ed Bednarczyk	IPA for Ellana Eberhardt, 1044868-1-34952,	PI	Western New York Veterans Administration

Ed Bednarczyk	Assessment of central mu opiate receptor occupancy after single doses of CP-866087 using positron emissiontomography (PET) in healthy adult subjects, 9103-545835	PI	Pfizer

Gayle Brazeau	Evaluation of Tissue Damage of Test Formulations, 1044065-1-34565	PI	Novartis

Gayle Brazeau	Formulation and Particle Size Effects on Toleration of Intramuscular Formulations, 1045054-1-35047	PI	Pfizer

Curtis Haas	Collaborative Program in Pharmacotherapy Research, Practice and Clinical Education Relative to Critically Ill Patients, 1042530-1-33754	PI	University Of Rochester

Curtis Haas	Clinical Study No. A3381009, 9103-524235	PI	Pfizer

Gene Morse	Opioids & HIV Medications Interactions in Drug Abusers, 1045067-1-35053	PI	Virginia Commonwealth University-Subcontract From National Institute On Drug Abuse

Gene Morse	Targeted Neuroprotection 1021524-1-23776	PI	University Of Rochester

Gene Morse	Adult Therapeutic Clinical Trials Program for Aids, 1045185-1-35116	PI	University Of Rochester

Gene Morse	AACTG Pharmacology Support Laboratory, 1045100-1-35067	PI	National Institute of Allergy and Infectious Diseases

Gene Morse	AACTG-QA/QC, 1048689-1-36576	PI	National Institute of Allergy and Infectious Diseases

Gene Morse	TDM & Drug Interactions in HIV Infected Substance Abusers, 1033722-1-29328, Subawards: University of Rochester , U of Miami , Montefiore Medical Ctr, Case Western	PI- Morse Co-I Forrest Co-I Brazeau, D.	National Institute On Drug Abuse

Gene Morse	Drug Interactions & Antiretroviral in Resource Poor Countries, 1048666-1-29328 Subaward: Zimbabwe	PI	National Institute On Drug Abuse

Gene Morse	ACTG-5146, 9103-522735	PI	Virco Labs

Gene Morse	Ryan White Title III, 1018487-1-22091	PI	Health Resources & Services Administration

Gene Morse	NYSDOH Adherence, 1018487-1-22091	PI	Heath Resources & Services Administration

Judianne Slish	Longitudinal Assessment of Protease Inhibitors in HIV/HCV/HBV Co-Infected Patients, 9103-548235	PI	Pfizer

Patrick Smith	Pharmacotherapy Residency in Oncology, 9103-536935	PI	Amgen

Patrick Smith	Human Serum on In Vitro Antibacterial Potency of Televancin, 9103-547435	PI	Theravance

Tornatore, Kathleen	Relationship of 2 Hr Cyclosporine Concentration Study, 9103-518135	PI	Novartis